002630 — Orient Bio Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩161bn
- KR₩137bn
- KR₩28bn
Annual cashflow statement for Orient Bio, fiscal year end - March 31st, KRW millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11,644 | -15,275 | 34,198 | -12,424 | 12,871 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2,722 | 19,153 | -33,942 | -4,384 | -13,141 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Purchased R&D | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.252 | 170 | -1,830 | 14,878 | 1,343 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4,672 | 8,739 | 2,351 | 1,160 | 3,757 |
| Capital Expenditures | -1,883 | -256 | -2,211 | -486 | -925 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1,536 | -3,777 | 18,981 | -20,172 | -2,191 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -347 | -4,033 | 16,770 | -20,658 | -3,116 |
| Financing Cash Flow Items | 4.5 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,816 | 3,875 | -1,134 | -6,792 | -570 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6,820 | 8,590 | 19,052 | -24,058 | 175 |